Evaluation of Sarcopenia in Elderly at the Emergency Department

NCT ID: NCT05567549

Last Updated: 2022-10-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-10-10

Study Completion Date

2023-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to evaluate in elderly patients for the frequency of sarcopenia and its relationship with mortality in a university hospital.

The main questions it aims to answer are;

1. What is the frequency of sarcopenia in elderly patients at emergency department?
2. Is sarcopenia associated with mortality in an elderly patient admitted to the emergency department?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Above the age of 65 admitted to the emergency department
2. Able to walk without support
3. No lower extremity fracture
4. No disease with neuromuscular involvement

Exclusion Criteria

1. In the presence of a cerebrovascular event
2. Those in need of critical intervention when applying to the emergency department
3. Unconscious patients
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ege University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ozge Can. MD

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ege University

Izmir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Özge Can

Role: primary

+905054499887

References

Explore related publications, articles, or registry entries linked to this study.

Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging. 2008 Aug-Sep;12(7):452-6. doi: 10.1007/BF02982705. No abstract available.

Reference Type BACKGROUND
PMID: 18615226 (View on PubMed)

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010 Jul;39(4):412-23. doi: 10.1093/ageing/afq034. Epub 2010 Apr 13.

Reference Type BACKGROUND
PMID: 20392703 (View on PubMed)

Roberts S, Collins P, Rattray M. Identifying and Managing Malnutrition, Frailty and Sarcopenia in the Community: A Narrative Review. Nutrients. 2021 Jul 5;13(7):2316. doi: 10.3390/nu13072316.

Reference Type BACKGROUND
PMID: 34371823 (View on PubMed)

Hung SK, Kou HW, Hsu KH, Wu CT, Lee CW, Leonard Goh ZN, Seak CK, Chen-Yeen Seak J, Liu YT, Seak CJ; SPOT investigators. Sarcopenia is a useful risk stratification tool to prognosticate splenic abscess patients in the emergency department. J Formos Med Assoc. 2021 Mar;120(3):997-1004. doi: 10.1016/j.jfma.2020.08.039. Epub 2020 Sep 9.

Reference Type BACKGROUND
PMID: 32917483 (View on PubMed)

McQuade C, Kavanagh DO, O'Brien C, Hunter K, Nally D, Hickie C, Ward E, Torreggiani WC. CT-determined sarcopenia as a predictor of post-operative outcomes in patients undergoing an emergency laparotomy. Clin Imaging. 2021 Nov;79:273-277. doi: 10.1016/j.clinimag.2021.05.015. Epub 2021 May 18.

Reference Type BACKGROUND
PMID: 34171595 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-8.1T/60

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sternocleidomastoid Thickness in Sarcopenia
NCT05928845 NOT_YET_RECRUITING
Understanding Acute Sarcopenia
NCT03858192 UNKNOWN NA